Quantcast
Last updated on April 21, 2014 at 1:20 EDT

Court Says Pradaxa Lawsuits Can Proceed as Bleeding Claims Top 100

September 14, 2012

The Pradaxa Resource Center is the Web´s largest source for information on Pradaxa legal news, research and side effects. Visit http://www.Pradaxa-lawsuits.org

Orlando, FL (PRWEB) September 14, 2012

The Pradaxa Resource Center, a patient advocacy group, is alerting patients who took the blood thinner Pradaxa that the drug has been linked to severe internal bleeding. A federal judge recently ruled that lawsuits by those injured may proceed, with more than 100 claims now pending.

Anyone affected by internal bleeding or the loss of a loved one from Pradaxa is urged to speak with a lawyer about their legal rights as soon as possible.

Pradaxa is a popular blood thinner prescribed to prevent strokes and blood clots in patients with atrial fibrillation. According to an August 27, 2012 report in the Berlin Ad Hoc News, manufacturer Boehringer Ingelheim claims Pradaxa has been prescribed for a combined total of one million patient-years and has been used in more than 70 countries.

On December 7, 2011, however, the FDA warned that it would launch an investigation into Pradaxa after receiving more injury or death reports than expected. According to a USA Today article on August 19, 2012, the agency received 3,781 reports of side effects and 542 deaths among Pradaxa users last year, leading all other medications in 2011.

Due to the number of Pradaxa lawsuits expected, a central court was recently established in Illinois to handle the claims. The case is known as MDL No. 2385, IN RE: Pradaxa Product Liability Litigation, Southern District of Illinois. On July 25th, Judge David Herndon issued an order denying attempts by Boehringer Ingelheim to dismiss Pradaxa bleeding lawsuits.

The United States Judicial Panel on Multidistrict Litigation indicated on September 5, 2012 that more than 100 Pradaxa side effect claims have now been filed. Judge Herndon has also set an initial hearing for October 3rd and indicated trials should start in 18 to 24 months.

Anyone affected by internal bleeding after Pradaxa use is urged to speak with a lawyer about their legal options as soon as possible. Due to the specialized nature of these federal MDL cases, the Pradaxa Resource center only recommends lawyers who are already handling Pradaxa lawsuits.

To speak with a lawyer, or for more information on the research, warnings, Pradaxa side effects, legal options or a Pradaxa death visit http://www.Pradaxa-lawsuits.org.

For the original version on PRWeb visit: http://www.prweb.com/releases/prwebpradaxa-side-effects/pradaxa-death/prweb9900934.htm


Source: prweb